newsfilter
← Latest News
GlobeNewswire·

AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency

OCALA, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM," or the "Company"), an immuno-pharma company focused on the development of therapeutics to treat multiple types of cancers, immune